Madame Bioscience PCL (BKK:MADAME) ROCE %: 11.61% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:MADAME Madame Bioscience PCL BKK:MADAME
34 GF Score
Price ฿0.96
GF Value ฿0.63
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Madame Bioscience PCL ROCE %?

Madame Bioscience PCL BKK:MADAME -4.95% 34 ROCE % is 11.61% as of Jun. 2026. GuruFocus rates BKK:MADAME with a GF Score™ of 34/100 and a GF Value™ of ฿0.63 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Madame Bioscience PCL's annualized ROCE % for the quarter that ended in Jun. 2026 was 11.61%.

Madame Bioscience PCL  (BKK:MADAME) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Madame Bioscience PCL ROCE % Related Terms

Madame Bioscience PCL ROCE % Historical Data

* Premium members only.

The historical data trend for Madame Bioscience PCL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Madame Bioscience PCL ROCE % Chart

Madame Bioscience PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.38 -27.55 -23.39 -29.34 9.25

Madame Bioscience PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.70 -4.23 -64.82 9.67 11.61
BKK:MADAME
34GF Score
Madame Bioscience PCL BKK:MADAME
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Madame Bioscience PCL ROCE % Calculation

Madame Bioscience PCL's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=82.62/( ( (1621.295 - 825.538) + (1316.92 - 326.97) )/ 2 )
=82.62/( (795.757+989.95)/ 2 )
=82.62/892.8535
=9.25 %

Madame Bioscience PCL's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=119.536/( ( (1289.336 - 277.916) + (1325.099 - 277.058) )/ 2 )
=119.536/( ( 1011.42 + 1048.041 )/ 2 )
=119.536/1029.7305
=11.61 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 11.61% mean?
Madame Bioscience PCL (BKK:MADAME) has a ROCE % of 11.61% as of Jun. 2026.
Is Madame Bioscience PCL's ROCE % too high?
Madame Bioscience PCL's current ROCE % is 11.61%. The Consumer Packaged Goods industry median ROCE % is 8.90. Madame Bioscience PCL's value of 11.61% is 30.4% above this industry median. Overall, Madame Bioscience PCL has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Madame Bioscience PCL's ROCE % compare to KHC and GIS?
Madame Bioscience PCL's ROCE % of 11.61% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.90. Madame Bioscience PCL's value of 11.61% is 30.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Consumer Packaged Goods company?
The median ROCE % among Consumer Packaged Goods companies is 8.90, based on 1,951 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Madame Bioscience PCL's current ROCE % of 11.61% is 30.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Madame Bioscience PCL's current ROCE % is 11.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Madame Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, Madame Bioscience PCL (BKK:MADAME) is currently considered Significantly Overvalued. The stock's GF Value™ is ฿0.63, compared to a current price of ฿0.96 — trading 52.4% above its estimated fair value. The current ROCE % is 11.61% and 30.4% above the Consumer Packaged Goods industry median of 8.90. Madame Bioscience PCL's overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Madame Bioscience PCL (BKK:MADAME), the current ROCE % is 11.61% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Madame Bioscience PCL (BKK:MADAME) Overvalued in 2026?

Based on GuruFocus' analysis, Madame Bioscience PCL stock appears to be overvalued. The current stock price of ฿0.96 is trading 52.4% above its estimated GF Value™ of ฿0.63. GuruFocus considers Madame Bioscience PCL to be Significantly Overvalued.

Key valuation signals for BKK:MADAME:

  • ROCE %: 11.61%
  • GF Value™: ฿0.63 vs. price of ฿0.96 (52.4% above fair value)
  • GF Score™: 34/100 with 5 warning signs
  • Industry Position: 30.4% above the Consumer Packaged Goods median

No single metric tells the full story. See the BKK:MADAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Madame Bioscience PCL Business Description

Address Praditmanutham Road, 60, 2nd Floor, Soi Praditmanutham 19, Lat Phrao, Lat Phrao, Bangkok, THA, 10230
Madame Bioscience PCL is engaged in the segments of the Packaging business, Food business, Retail sales of cosmetics, and Other businesses. Its activities include the manufacturing and selling of plastic packaging, restaurant business, advertising rental service in the gas station and manufacturing and selling of dried fruits, among others. The group derives a majority of its revenue from the Food business. The firm's product portfolio includes Ready meals, Frozen food, value-added seafood and vegetables, Flexible packaging, and PET Bottles.
34GF Score

Get the complete analysis for BKK:MADAME

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.96
Price
฿0.63
GF Value